Literature DB >> 11192371

Adaptive mechanisms of the cardiovascular system in transgenic mice--lessons from eNOS and myoglobin knockout mice.

A Gödecke1, J Schrader.   

Abstract

Transgenic mice have turned out to be important in the analysis of cardiovascular physiology and pathology. A large number of gene knockout and overexpression models have been generated, including genes involved in blood pressure regulation, cardiac function and hemostasis. In this review we concentrate on two models, the endothelial NO synthase and the myoglobin knockout mice. It will be shown that the genetic approach of gene function analysis in mice not only provides new insight into the actual role of the encoded gene product, but also uncovers possible secondary alterations which compensate for the induced change. In the case of NOS knockout mice, upregulation of other NOS isoforms, induction of signal molecules such as prostaglandins or endothelium-derived hyperpolarizing factor may conserve the vasodilatory potential of NOS deficient vessels. In the case of myoglobin knockout mice, even structural changes may contribute to compensate a loss of gene function as shown by the elevated capillary density, which may enhance the oxygen supply to mitochondria. Thus, results obtained by the analysis of gene function in transgenic animals may differ from acute pharmacological interventions in that they reveal the striking ability of an intact organism to effectively adapt to chronic changes in gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11192371     DOI: 10.1007/s003950070026

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  9 in total

1.  An acute rise in intraluminal pressure shifts the mediator of flow-mediated dilation from nitric oxide to hydrogen peroxide in human arterioles.

Authors:  Andreas M Beyer; Matthew J Durand; Joseph Hockenberry; T Clark Gamblin; Shane A Phillips; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

2.  Contributions of nitric oxide synthases, dietary nitrite/nitrate, and other sources to the formation of NO signaling products.

Authors:  Alexandra B Milsom; Bernadette O Fernandez; Maria F Garcia-Saura; Juan Rodriguez; Martin Feelisch
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

3.  Characterization of mitochondrial ferritin-deficient mice.

Authors:  Thomas B Bartnikas; Dean R Campagna; Brendan Antiochos; Howard Mulhern; Corinne Pondarré; Mark D Fleming
Journal:  Am J Hematol       Date:  2010-12       Impact factor: 10.047

4.  Basal Vascular Smooth Muscle Cell Tone in eNOS Knockout Mice Can Be Reversed by Cyclic Stretch and Is Independent of Age.

Authors:  Sofie De Moudt; Jhana O Hendrickx; Guido R Y De Meyer; Wim Martinet; Paul Fransen
Journal:  Front Physiol       Date:  2022-04-28       Impact factor: 4.755

5.  Regulation of cellular respiration in myoglobin-deficient mouse heart.

Authors:  Erkki V Liimatta; Axel Gödecke; Jürgen Schrader; Ilmo E Hassinen
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

6.  Dietary nitrite restores NO homeostasis and is cardioprotective in endothelial nitric oxide synthase-deficient mice.

Authors:  Nathan S Bryan; John W Calvert; Susheel Gundewar; David J Lefer
Journal:  Free Radic Biol Med       Date:  2008-05-05       Impact factor: 7.376

Review 7.  Thrombospondin-1, Free Radicals, and the Coronary Microcirculation: The Aging Conundrum.

Authors:  Amanda J LeBlanc; Natia Q Kelm
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

8.  Increased 5-HT(3)-mediated signalling in pelvic afferent neurons from mice deficient in P2X(2) and/or P2X (3) receptor subunits.

Authors:  Bei Ma; Gregory Wynn; Philip M Dunn; Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2006-07-04       Impact factor: 3.765

Review 9.  Nitric oxide and coronary vascular endothelium adaptations in hypertension.

Authors:  Andrew S Levy; Justin C S Chung; Jeffrey T Kroetsch; James W E Rush
Journal:  Vasc Health Risk Manag       Date:  2009-12-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.